Diabetes Reports
Forecast Insight: Antidiabetics
Switching to New Molecule Antidiabetics Drives Market Growth
Publisher: Datamonitor, Date Published: August 2008
Pipeline Insight: Insulin Antidiabetics
Return to injections alternative delivery methods fall by the wayside
Publisher: Datamonitor, Date Published: July 2008
Innovations in The Management of Diabetes:
Next generation treatments and market dynamics
Publisher: Business Insights, Date Published: June 2008
Type-2 Diabetes Pipeline
Therapeutic Area Clinical Intelligence
Publisher: Austin Research Group, Date Published: June 2008
Stakeholder Insight: Diabetes
Publisher: Datamonitor, Date Published: December 2007
Commercial Insight: Antidiabetics
Patent expiries and cost containment initiatives balanced by pipe
Publisher: Datamonitor, Date Published: August 2007
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
Publisher: Datamonitor, Date Published: July 2007
Commercial Insight: Antidyslipidemics
The competitive cost-conscious antidyslipidemics market presents challenges
Publisher: Datamonitor, Date Published: July 2007
Blood Glucose Testing and Diabetes Management
Publisher: TriMark Publications, Date Published: July 2007
Blood and Lymphatic System - Dyslipidemia Drug Pipeline Report
Publisher: Life Science Analytics, Date Published: June 2007
Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market
Publisher: Datamonitor, Date Published: April 2007
Pipeline Insight: Dyslipidemia - Pipeline agents unlikely to rejuvenate the market
Publisher: Datamonitor, Date Published: April 2007
Stakeholder Insight: Atherosclerosis
HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment
Publisher: Datamonitor, Date Published: December 2006
Commercial and Pipeline Perspectives: Obesity - Lack of Reimbursement Limits Market Potential
Publisher: Datamonitor, Date Published: December 2006
Commercial Insight: Antithrombotics
Pipeline products to dampen the impact of patent expiries and cost containment initiatives
Publisher: Datamonitor, Date Published: December 2006
Stakeholder Insight: Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook
Publisher: Datamonitor, Date Published: October 2006
Commercial Insight: Antihypertensives - New challenges for a maturing market
Publisher: Datamonitor, Date Published: September 2006
Pipeline Insight: Insulins - Inhalable insulins unlikely to become blockbusters
Publisher: Datamonitor, Date Published: September 2006
Commercial Insight: Antidiabetics
Patent expiries and cost containment initiatives balanced by pipeline products
Publisher: Datamonitor, Date Published: August 2006
Pipeline Insight: Non-insulin Antidiabetics
Type 2 diabetes unlikely to develop into a switch market
Publisher: Datamonitor, Date Published: August 2006
The Global Diabetes Market
Therapeutics, Diagnostics and Complications
Publisher: Arrowhead Publishers, Date Published: August 2006
Commercial Insight: Antidyslipidemics - Branded statins beware, generics are amongst you
Publisher: Datamonitor, Date Published: July 2006
Pipeline Insight: Antiarrhythmics - RSD1235 in a class of its own
Publisher: Datamonitor, Date Published: May 2006
The Diabetes Market Outlook to 2011
Publisher: Business Insights, Date Published: May 2006
Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
Publisher: Datamonitor, Date Published: April 2006
